Diabetes Stocks
Discover investment opportunities in Diabetes Stocks using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Diabetes Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Diabetes Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Diabetes Stocks using our Smart AI Filter.
8 stocks found for "Diabetes Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
1.50 Risk measure | ±76.4% Price volatility | -13.9 Valuation | 0.00% Annual yield | |||
0.59 Risk measure | ±31.6% Price volatility | 34.5 Valuation | 0.77% Annual yield | |||
1.02 Risk measure | ±49.1% Price volatility | 40.9 Valuation | 0.00% Annual yield | |||
0.49 Risk measure | ±19.6% Price volatility | 26.1 Valuation | 1.76% Annual yield | |||
0.76 Risk measure | ±41.4% Price volatility | 25.6 Valuation | 0.00% Annual yield | |||
0.72 Risk measure | ±40.2% Price volatility | 17.0 Valuation | 3.18% Annual yield | |||
2.07 Risk measure | ±100.0% Price volatility | -4.2 Valuation | 0.00% Annual yield | |||
0.80 Risk measure | ±35.4% Price volatility | 77.8 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Eli Lilly (LLY) closed at $762.18 in the latest trading session, marking a -1.23% move from the prior day.
Read moreHere is how DexCom (DXCM) and Amarin (AMRN) have performed compared to their sector so far this year.
Read moreThe heavy selling pressure might have exhausted for Tandem Diabetes Care (TNDM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read moreSeveral women who have reported improvements in symptoms of polycystic ovary syndrome, a common hormonal disorder, after using GLP-1s such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound. Patients and some health experts view GLP-1s as a promising potential option for a condition that lacks a standard treatment and affects millions of women in the U.S.
Read moreThe most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Read moreTariff threats are fueling a new wave of U.S. manufacturing investments from the pharmaceutical industry.
Read more